Researchers in Idaho have found that a little lidocaine gel applied topically reduces breast discomfort experienced during mammography.
The simple technique could lead more women to comply with recommended guidelines for mammographic screening.
Lead investigator Colleen Lambertz, and colleagues at St. Luke's Mountain States Tumor Institute in Boise recruited 418 women ages 32 to 89 scheduled for mammography screening. Fifty-four of them had reportedly delayed their exams over discomfort fears. They were randomized for medication with acetaminophen, ibuprofen, lidocaine gel, or placebos before mammography. Women who received a topical application reported significantly less breast discomfort during mammography. The study was published in the September issue of Radiology.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.